Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

An important breakthrough in the fight against muscular dystrophies

13.09.2012
Recent findings by an international collaboration including IRCM researchers hold new implications for the pathogenesis of myotonic dystrophy
An important breakthrough could help in the fight against myotonic dystrophy. The discovery, recently published in the prestigious scientific journal Cell, results from an international collaboration between researchers at the IRCM, the Massachusetts Institute of Technology (MIT), the University of Southern California and Illumina. Their findings could lead to a better understanding of the causes of this disease.

Myotonic dystrophy (DM), also known as Steinert's disease, is the most common form of muscular dystrophies seen in adults. This disorder is characterized by muscle weakness and myotonia (difficulty in relaxing muscles following contraction). It is a multi-system disease, typically involving a wide range of tissues and muscle.

“We studied a specific family of proteins called muscleblind-like proteins (Mbnl), which were first discovered in the fruit fly Drosophila melanogaster,” says Dr. Éric Lécuyer, Director of the RNA Biology research unit at the IRCM. “These RNA-binding proteins are known to play important functions in muscle and eye development, as well as in the pathogenesis of DM in humans.”

Because of the extreme heterogeneity of clinical symptoms, DM has been described as one of the most variable and complicated disorders known in medicine. The systems affected, the severity of symptoms, and the age of onset of those symptoms greatly vary between individuals, even within the same family.

“In patients with DM, levels of Mbnl proteins are depleted to different extents in various tissues,” explains Dr. Neal A.L. Cody, postdoctoral fellow in Dr. Lécuyer’s laboratory. “These alterations in levels and functions of Mbnl proteins are thought to play an important role in causing the disease.”

“The global transcriptome analyses conducted in this study yielded several insights into Mbnl function and established genomic resources for future functional, modeling, and clinical studies,” add Drs. Christopher B. Burge and Eric T. Wang from MIT, the researchers who headed the study. “This knowledge will be invaluable in reconstructing the order of events that occur during DM pathogenesis, and could lead to the development of diagnostic tools for monitoring disease progression and response to therapy.”

According to Muscular Dystrophy Canada, myotonic dystrophy is the most common form of muscle disease, affecting approximately one person in 8,000 worldwide. However, in Quebec’s region of Charlevoix / Saguenay-Lac-Saint-Jean, the prevalence is exceptionally high, with one person in 500 affected by the disease. There is no cure for myotonic dystrophy at the present time. Treatment is symptomatic, meaning that problems associated with myotonic dystrophy are treated individually.
About the research project
This research project was funded by grants from the National Institutes of Health (NIH) to Christopher B. Burge and by an NIH training grant and a Muscular Dystrophy Foundation fellowship to Eric T. Wang. Work conducted by Neal A.L. Cody in Dr. Lécuyer’s laboratory was funded by the Fonds de Recherche du Québec – Santé.

The article published in Cell, Transcriptome-wide Regulation of Pre-mRNA Splicing and mRNA Localization by Muscleblind Proteins, was prepared by Eric T. Wang, Thomas T. Wang, Daniel J. Treacy, David E. Housman and Christopher B. Burge from the David K. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT); Neal A.L. Cody and Éric Lécuyer from the IRCM; Sonali Jog, Michela Biancolella and Sita Reddy from the University of Southern California; and Shujun Luo and Gary P. Schroth from Illumina Inc.

For more information on this scientific breakthrough, please refer to the article summary published online by Cell: http://www.cell.com/abstract/S0092-8674(12)00885-9.

About Dr. Éric Lécuyer
Éric Lécuyer obtained his PhD in molecular biology from the Université de Montréal. He is an Assistant IRCM Research Professor and Director of the RNA Biology research unit. Dr. Lécuyer is assistant professor-researcher in the Department of Biochemistry at the Université de Montréal. He is also adjunct professor in the Department of Medicine (Division of Experimental Medicine) at McGill University. Dr. Lécuyer is a research scholar from the Fonds de recherche du Québec – Santé. For more information, visit www.ircm.qc.ca/lecuyer.

About the IRCM
Founded in 1967, the Institut de recherches cliniques de Montréal (IRCM) (www.ircm.qc.ca) is currently comprised of 37 research units in various fields, namely immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry. It also houses three specialized research clinics, eight core facilities and three research platforms with state-of-the-art equipment. The IRCM employs 425 people and is an independent institution affiliated with the Université de Montréal. The IRCM clinic is associated to the Centre hospitalier de l’Université de Montréal (CHUM). The IRCM also maintains a long-standing association with McGill University.

Download the news release as a PDF document
http://www.ircm.qc.ca/Medias/Communiques/Documents/20120912_IRCMRelease
_LecuyerCell.pdf
For more information and to schedule an interview with Dr. Lécuyer, please contact:
Julie Langelier
Communications Officer (IRCM)
julie.langelier@ircm.qc.ca
(514) 987-5555

Lucette Thériault
Communications Director (IRCM)
lucette.theriault@ircm.qc.ca
(514) 987-5535

Julie Langelier | EurekAlert!
Further information:
http://www.ircm.qc.ca

More articles from Health and Medicine:

nachricht Scientists learn more about how gene linked to autism affects brain
19.06.2018 | Cincinnati Children's Hospital Medical Center

nachricht Overdosing on Calcium
19.06.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Creating a new composite fuel for new-generation fast reactors

20.06.2018 | Materials Sciences

Game-changing finding pushes 3D-printing to the molecular limit

20.06.2018 | Materials Sciences

Could this material enable autonomous vehicles to come to market sooner?

20.06.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>